Creative Biolabs-Immuno-oncology

Anti-CD4 (clone TRX1G) SynExpress E1-TG-NF-X Modified CD8+ T cells (CAT#: ITS-1224-CR1462)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD4 (clone TRX1G). We employs the AAV (EF1α-TurboGFP-NF-κB-XbaI) vector components and the SynExpress system of the Exons Deletion/Delayed feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD4
Clone
TRX1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
TurboGFP
Promoter
EF1α
Effector Gene
NF-κB
Insertion Sites
XbaI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
AAV
Transformation Accuracy
0.98
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.